RxDoctor Payments Data

Samuel Wilson, MD

Emergency Medicine · Hesperia, CANPI 1912948019

Payments from drug & device makers

$480in general payments, 2019–2025

Across 23 payments — averaging $20.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$139
  • Mannkind Corporation$134
  • Boehringer Ingelheim$54
  • Sanofi Pasteur Inc.$40
  • Dexcom, Inc.$37
  • Exact Sciences$23
  • plus $54 from 4 others

What the payments were for

  • Food & beverage$42188%
  • Gifts$5912%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$480 in reported general payments places this provider in the 90th percentile of 6,006 emergency medicine providers in California.

See all emergency medicine providers in California

Medicare billing

Part B allowed, 2024
$4,364
Medicare patients
23
Services billed
34

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin255$248,429
MounjaroTirzepatide144$156,928
OzempicSemaglutide134$129,809
TrulicityDulaglutide103$99,741
EliquisApixaban81$61,702
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog176$52,618
JanuviaSitagliptin Phosphate27$26,262
InvokanaCanagliflozin21$17,106
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$16,728
ProzacFluoxetine Hcl27$15,728
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog18$14,151
BrilintaTicagrelor23$13,301
Albuterol Sulfate HfaAlbuterol Sulfate222$9,125
TradjentaLinagliptin14$7,606
Humalog Kwikpen U-100Insulin Lispro39$6,976

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$139$256,669247 claims
Boehringer IngelheimJardiance, Tradjenta$54$256,035269 claims
Novo NordiskOzempic$14$129,809134 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,006 emergency medicine providers in California.

Other emergency medicine in Hesperia

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →